FDA Recalls Phenylephrine Injectable Due to Sterility Concerns
Central Admixture Pharmacy Services is recalling 5,304 bags of phenylephrine injection nationwide after FDA inspection raised concerns about product sterility assurance.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall of injectable medication with potential sterility issues. No illnesses or injuries reported; the hazard is based on lack of sterility assurance following FDA inspection. This is a risk-of-harm product without reported injury, scoring at the High level per the rubric.
Plain-English summary
Central Admixture Pharmacy Services, Inc. is recalling 5,304 bags of phenylephrine injection (25 mg per 250 mL in 0.9% sodium chloride, 100 mcg/mL). The recall was initiated after an FDA inspection called into question the sterility assurance of these injectable products.
The affected product was distributed nationwide throughout the United States. Twelve different lot numbers are included in this recall, with expiration dates ranging from May 2, 2023 to June 29, 2023. The product is identified by NDC 71285-7011-1.
No illnesses or injuries have been reported in connection with this recall. The issue was identified through FDA inspection of the manufacturer's processes.
The recalled product
- Product
- PHENYLephrine added to 0.9% sodium chloride, 25 mg/250 mL* (100 mcg/mL), 250 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., 6580 Snowdrift Rd., Ste 100, Allentown, PA 18106, NDC 71285-7011-1.
- Manufacturer
- Central Admixture Pharmacy Services, Inc.
- Category
- Drug — Injectable
- Hazard
- sterility
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lot # 37-883924
- Exp 05/02/2023
- 37-884918
- Exp 05/07/2023
- 37-885677
- Exp 05/09/2023
- 37-887318
- Exp 05/16/2023
- 37-889211
- Exp 05/23/2023
- 37-889848
- Exp 05/25/2023
- 37-891150
- Exp 05/31/2023
- 37-892482
- Exp 06/06/2023
- 37-894484
- Exp 06/13/2023
- 37-896458
- 37-896480
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27